System | Type | Disorder | Pubmed |
cancer | | | |
novel molecular target for in vivo scintigraphy and targeted radiotherapy for a variety of GLP1 receptor-expressing tumors |
neurology | neurodegenerative | Parkinson/dementia Parkinsonism | |
GLP1R agonists (Exendin4) may exert various useful actions in persons at high risk for stroke or with Parkinson disease, a hypothesis that is amenable to clinical testing |
cardiovascular | atheroma | | |
GLP1R agonists seem to have direct effects on the cells involved in the progression of atherosclerosis, such as endothelial cells or macrophages |
miscelleaneous | vascular | ischemic injury | |
EX4, GLP1R agonists reduced intimal thickening after vascular injury |
diabete | type 2 | | |
GLP1R agonists may help design new therapies for cardiovascular disease in patients with type 2 diabetes |